Pfizer coronavirus vaccine passes safety checks and is 95% effective

direct to your inboxProfessor Jonathan Van-Tam led a Downing Street briefing on the potential coronavirus vaccine on Wednesday morning.Following the successful news that the Pfizer/BioNTech Covid-19 vaccine interim results show that it's 90 per cent effective, many questions have been raised about the likely roll out.The UK has secured 30 million doses of the Pfizer/BioNTech vaccine – the first agreement the firms signed with any government.But is thought people will need two doses, meaning not

direct to your inboxDr Hilary Jones has expressed caution over the coronavirus vaccine as it begins its roll-out in the UK. The first two people to receive the Pfizer/BioNTech Covid-19 vaccine had been given their first dose before 8am on Tuesday morning.

NHS has said it will contact the people who are first in line for a vaccine. People who already have hospital appointments booked for next week are likely to be asked first.Then, in the coming weeks, GPs operating local vaccination centres will also begin to contact those eligible for a vaccine in their local area.There will be 50 NHS vaccine hubs set up in hospitals across England to administer the first vaccinations next week.

direct to your inboxThe Pfizer/BioNTech coronavirus vaccine has been approved for use in the UK - the first country in the world to do so.The government on Wednesday accepted a recommendation by the Medicines and Healthcare products Regulatory Agency (MHRA), with vaccinations to start next week.It comes on the day that England has returned to a 'strengthened' three-tier system to control the spread of coronavirus.Those in the top tier - Tier 3 - may be left wondering if they could be first to

direct to your inboxThe UK is the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine.On Wednesday the government accepted a recommendation by the Medicines and Healthcare products Regulatory Agency (MHRA), with mass vaccination to start next week.The announcement comes just weeks after phase three clinical trials showed the vaccine was 95 per cent effective with two doses.In November, when the two companies announced the successful results from the phase three clinical

A new report from Pfizer has come out of their coronavirus vaccine trials about the success rate of the vaccine they have been developing to help eradicate the pandemic.

coronavirus vaccine is 95 percent effective and works in older people, according to new data from the firm. The drugs giant and its partner BioNTech said that the latest figures from their 170 trial participants showed the jag worked in helping prevent people catching Covid-19.

coronavirus vaccine was 94.5 percent effective, based on early results from its large, continuing study in the United States.